ACT-Accelerator | 02 Apr 2021

Why in News

Carl Bildt has been appointed as WHO Special Envoy for the Access to Covid-19 Tools Accelerator (ACT-Accelerator).

• The ACT-Accelerator is a groundbreaking global collaboration to accelerate development, production, and equitable access to Covid-19 tests, treatments and vaccines.

Key Points

• ACT-Accelerator:
  
  • It was launched in the month of April, 2020 at an event co-hosted by the Director-General of the World Health Organization (WHO), the President of France, the President of the European Commission, and the Bill & Melinda Gates Foundation.
  • It brings together governments, scientists, businesses, civil society, and philanthropists and global health organizations.
    
    • The participants include the Bill & Melinda Gates Foundation, CEPI, Foundation for Innovative New Diagnostics (FIND), Gavi, The Global Fund, Unitaid, Wellcome Trust (London), the WHO and the World Bank.
  • It aims to end the pandemic, restore full societal and economic activity globally and facilitate high-level control of Covid-19 disease.
  • The ACT-Accelerator is organized into four pillars of work:
    
    • Diagnostics, treatment, vaccines and health system strengthening.
    • Each pillar is vital to the overall effort and involves innovation and collaboration.
• COVAX:
  
  • COVAX is one of four pillars of the ACT Accelerator.
  • It is an effort to ensure that people in all corners of the world will get access to Covid-19 vaccines, regardless of their wealth.
    
    • The initial aim is to have 2 billion doses available by the end of 2021, which should be enough to protect high risk and vulnerable people, as well as frontline healthcare workers.
  • It is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organisation (WHO), working in partnership with vaccine manufacturers of developed and developing countries.
  • India’s Role:
    
    • India has started shipping Covid-19 vaccines to Africa under the COVAX facility.
    • Earlier, Serum Institute of India (SII) had received funds from Gavi and the Bill and Melinda Gates Foundation to double its supply of Covid-19 vaccines (200 million doses) to India and other poorer countries as part of the Gavi COVAX facility.
• Significance of ACT-Accelerator:
  
  • It is a crucial time for ACT-Accelerator when the world is rolling out vaccines against Covid-19, introducing new diagnostics and scaling up life-saving oxygen and corticosteroids for severe disease.
  • It will help in addressing the uneven distribution of vaccines globally and the emergence of new variants of concern.

Source: DTE